ML Decision Model for G-NEC Adjuvant Therapy

CompletedOBSERVATIONAL

Enrollment

1,505

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

June 1, 2024

Study Completion Date

June 30, 2024

Conditions

Gastric Neuroendocrine Carcinoma (G-NEC)Postoperative Adjuvant Therapy for G-NECSurvival OutcomesMachine Learning

Trial Locations (1)

Fujian Medical University, Fuzhou

All Listed Sponsors

lead

Chang-Ming Huang, Prof.

OTHER

NCT06663852 - ML Decision Model for G-NEC Adjuvant Therapy | Biotech Hunter | Biotech Hunter